AI-generated summary
The authors retrospectively reviewed 230 lesions in 208 patients with stable refractory vitiligo treated with motorized 0.8-mm micropunch grafting. They report that 78.7% of lesions reached at least 75% repigmentation after a median of 6 months with postoperative excimer therapy. Common adverse events included color mismatch and a cobblestone appearance.
- Participants
- 208
- Who or what was studied
- Patients with stable refractory vitiligo (208 patients, 230 lesions) who underwent motorized 0.8-mm micropunch grafting between January 2015 and August 2017.
- Limits stated in the abstract
- This was a retrospective study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.